Revolution Medicines Inc (NASDAQ:RVMD) shares gained 5.8% on Monday after the company announced that the U.S. Food and Drug ...

Investing.com -- Revolution Medicines Inc (NASDAQ:RVMD) stock rose 5.8% on Monday after the company announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to ...

Orphan Drug Designation The purpose of the Orphan Product program is to support the development and evaluation of new treatments for rare diseases. FDA grants Orphan Drug designation to ...

As Halloween approaches, a Watford flat inside a former school and “straight out of a ghost story” is heading to auction.

CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma Patients Showed Extended Progression Free Survival and Overall Survival ...

The Food and Drug Administration granted orphan drug designation to Revolution Medicines' treatment for pancreatic cancer. The drug, called daraxonrasib, is being studied in a global phase three ...

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that the U.S. Food and Drug ...

Nordic oats are a reality. Scientists and producers are working together to increase production in northern Europe. Oats have ...

Conference call today at 8:30 a.m. ETCAMBRIDGE, Mass., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on ...

Ahead of its UK theatrical release this November, a new trailer and poster have been released for the 1970s-set fantasy drama ...

When the whole world bid goodbye to the former Prime Minister Raila Odinga on October 19, 2025, it signalled a new era in ...

This critically acclaimed sci-fi series revolutionized television with its unique storytelling and Tatiana Maslany's ...